Human cytomegalovirus latent infection and associated viral gene expression.

Human cytomegalovirus (HCMV) is a clinically important and ubiquitous herpesvirus. Following primary productive infection the virus is not completely eliminated from the host, but instead establishes a lifelong latent infection without detectable virus production, from where it can reactivate at a later stage to generate new infectious virus. Reactivated HCMV often results in life-threatening disease in immunocompromised individuals, particularly allogeneic stem cell and solid organ transplant recipients, where it remains one of the most difficult opportunistic pathogens that complicate the care of these patients. The ability of HCMV to establish and reactivate from latency is central to its success as a human pathogen, yet latency remains very poorly understood. This article will cover several aspects of HCMV latency, with a focus on current understanding of viral gene expression and functions during this phase of infection.

[1]  T. Shenk,et al.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Sissons,et al.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. , 1991, The Journal of general virology.

[3]  A. Cunningham,et al.  Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. , 2006, Blood.

[4]  T. Shenk,et al.  UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Alexander,et al.  Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence , 2004, Journal of Virology.

[6]  P. Lehner,et al.  An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. , 2005, The Journal of general virology.

[7]  M. Yoder,et al.  Working hypothesis to redefine endothelial progenitor cells , 2007, Leukemia.

[8]  F. Goodrum,et al.  Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. , 2004, Blood.

[9]  E. Mocarski,et al.  Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. , 1999, Blood.

[10]  E. Kieff,et al.  The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle , 1992, Journal of virology.

[11]  J. Maciejewski,et al.  Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form , 2004, British journal of haematology.

[12]  T. Schall,et al.  Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10 , 2002, Journal of Virology.

[13]  J. Cohen,et al.  Varicella-Zoster Virus ORF4 Latency-Associated Protein Is Important for Establishment of Latency , 2005, Journal of Virology.

[14]  F. Goodrum,et al.  Characterization of a Novel Golgi Apparatus-Localized Latency Determinant Encoded by Human Cytomegalovirus , 2009, Journal of Virology.

[15]  T. Gardella,et al.  Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis , 1984, Journal of virology.

[16]  W. Szmuness,et al.  A serologic study of cytomegalovirus infections associated with blood transfusions. , 1971, The New England journal of medicine.

[17]  D. Thorley-Lawson,et al.  Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals , 1996, Journal of virology.

[18]  M. Cannon,et al.  The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. , 2006, Journal of women's health.

[19]  J. Grundy,et al.  Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne, or Davis strains , 1999, Journal of medical virology.

[20]  D. McGeoch,et al.  The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. , 2003, The Journal of general virology.

[21]  S. Spector,et al.  Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages , 1991, Journal of virology.

[22]  R. L. Thompson,et al.  Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency , 1992, Journal of virology.

[23]  J. Wiedeman,et al.  Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection. , 2000, Virology.

[24]  J. Maciejewski,et al.  Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. , 1997, Blood.

[25]  C. Bruggeman,et al.  Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. , 1997, Journal of clinical pathology.

[26]  B. Slobedman,et al.  Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. , 2008, Virology.

[27]  C. J. Beall,et al.  The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. , 1995, Biochemical and biophysical research communications.

[28]  N. Fraser,et al.  Herpes simplex virus latency-associated transcript gene function , 2003, Journal of NeuroVirology.

[29]  M. Jarvis,et al.  Human Cytomegalovirus Tropism for Endothelial Cells: Not All Endothelial Cells Are Created Equal , 2006, Journal of Virology.

[30]  R. L. Thompson,et al.  The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency , 1997, Journal of virology.

[31]  J. Andersson,et al.  Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. , 1998, The American journal of pathology.

[32]  N. Young,et al.  Infection of hematopoietic progenitor cells by human cytomegalovirus. , 1992, Blood.

[33]  D. Knipe,et al.  Chromatin control of herpes simplex virus lytic and latent infection , 2008, Nature Reviews Microbiology.

[34]  M. Wills,et al.  Latency and reactivation of human cytomegalovirus. , 2002, The Journal of infection.

[35]  J. Xu,et al.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  N. Fraser,et al.  Detection of herpes simplex virus type 1 transcripts during latent infection in mice , 1987, Journal of virology.

[37]  M. Lock,et al.  Regions of the Herpes Simplex Virus Type 1 Latency-Associated Transcript That Protect Cells from Apoptosis In Vitro and Protect Neuronal Cells In Vivo , 2002, Journal of Virology.

[38]  P. Kitslaar,et al.  The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. , 1989, The American journal of pathology.

[39]  J. Cohen,et al.  Varicella-Zoster Virus Open Reading Frame 21, Which Is Expressed during Latency, Is Essential for Virus Replication but Dispensable for Establishment of Latency , 2003, Journal of Virology.

[40]  G. Jahn,et al.  Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules. , 2006, The Journal of general virology.

[41]  S. Crowe,et al.  Enhanced monocyte Fc phagocytosis by a homologue of interleukin-10 encoded by human cytomegalovirus. , 2009, Virology.

[42]  J. Sissons,et al.  Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. , 1993, The Journal of general virology.

[43]  A. Nesburn,et al.  Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. , 2000, Science.

[44]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[45]  S. Larsson,et al.  Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time , 1998, Transfusion.

[46]  G. Rice,et al.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Walker,et al.  Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population , 1991, British journal of haematology.

[48]  B. Plachter,et al.  The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. , 2009, Blood.

[49]  I. Rigoutsos,et al.  Reevaluation of human cytomegalovirus coding potential , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Ling Jin,et al.  Expression of the Pseudorabies Virus Latency-Associated Transcript Gene during Productive Infection of Cultured Cells , 1999, Journal of Virology.

[51]  C. Prober,et al.  Prevention of transfusion-acquired cytomegalovirus infections in newborn infants , 1981 .

[52]  J. Sissons,et al.  Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow , 1994, Journal of virology.

[53]  E Tom,et al.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.

[54]  T. Schall,et al.  Functional Analysis of the Human Cytomegalovirus US28 Gene by Insertion Mutagenesis with the Green Fluorescent Protein Gene , 1998, Journal of Virology.

[55]  J. Strominger,et al.  Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Nesburn,et al.  Identification of Herpes Simplex Virus Type 1 Latency-Associated Transcript Sequences That both Inhibit Apoptosis and Enhance the Spontaneous Reactivation Phenotype , 2003, Journal of Virology.

[57]  藤井 良知 Cytomegalovirus , 1966, Definitions.

[58]  J. Prchal,et al.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.

[59]  J. Sinclair,et al.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. , 1996, The Journal of general virology.

[60]  F. Goodrum,et al.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  B. Weinshenker,et al.  Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. , 1988, Journal of immunology.

[62]  J. Sissons,et al.  Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. , 2004, The Journal of general virology.

[63]  B. Sénéchal,et al.  Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. , 1996, Blood.

[64]  P. Deegen,et al.  Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation , 2009, Journal of Virology.

[65]  M. Reeves,et al.  Aspects of human cytomegalovirus latency and reactivation. , 2008, Current topics in microbiology and immunology.

[66]  M. Debakey,et al.  Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta , 2000, Virchows Archiv.

[67]  F. Geissmann The origin of dendritic cells , 2007, Nature Immunology.

[68]  C. Arias,et al.  Origin and differentiation of dendritic cells. , 2001, Trends in immunology.

[69]  E. Mocarski,et al.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  P. Lehner,et al.  Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  B. Plachter,et al.  Tissue macrophages are infected by human cytomegalovirus in vivo. , 1996, The Journal of infectious diseases.

[72]  D. Rock,et al.  Detection of HSV-1 genome in central nervous system of latently infected mice , 1983, Nature.

[73]  E. Mocarski,et al.  Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. , 2002, Blood.

[74]  P. Murphy,et al.  Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. , 1994, The Journal of biological chemistry.

[75]  J. Sinclair,et al.  Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers , 1994, Journal of virology.

[76]  J. Virelizier,et al.  Latently Infected Thp-1 Monocytes Receptor Gene Us28 Is Transcribed in Human Cytomegalovirus Chemokine , 2000 .

[77]  M. Reeves,et al.  Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. , 2010, The Journal of general virology.

[78]  A. Nesburn,et al.  A Herpes Simplex Virus Type 1 Latency-Associated Transcript Mutant with Increased Virulence and Reduced Spontaneous Reactivation , 1999, Journal of Virology.

[79]  B. Barrell,et al.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. , 1990, Current topics in microbiology and immunology.

[80]  M. Jordan Latent infection and the elusive cytomegalovirus. , 1983, Reviews of infectious diseases.

[81]  T. Lazzarotto,et al.  Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[82]  P. Ghazal,et al.  Human cytomegalovirus productively infects primary differentiated macrophages , 1991, Journal of virology.

[83]  D. Taylor,et al.  Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. , 1989, BMJ.

[84]  A. Nesburn,et al.  The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency , 1994, Journal of virology.

[85]  A. Doster,et al.  The Herpes Simplex Virus Type 1 Locus That Encodes the Latency-Associated Transcript Enhances the Frequency of Encephalitis in Male BALB/c Mice , 2005, Journal of Virology.

[86]  J. Cohen,et al.  The Varicella-Zoster Virus Open Reading Frame 63 Latency-Associated Protein Is Critical for Establishment of Latency , 2004, Journal of Virology.

[87]  R. Cohrs,et al.  Configuration of latent varicella-zoster virus DNA , 1995, Journal of virology.

[88]  D. Metcalf Hemopoietic growth factors and marrow transplantation: an overview. , 1989, Transplantation proceedings.

[89]  P. Barry,et al.  Human Cytomegalovirus-Encoded Interleukin-10 Homolog Inhibits Maturation of Dendritic Cells and Alters Their Functionality , 2004, Journal of Virology.

[90]  E. Mocarski,et al.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[91]  V. Štolc,et al.  Functional profiling of a human cytomegalovirus genome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[92]  B. Slobedman,et al.  A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection , 2004, Journal of Virology.

[93]  J. Cohen,et al.  Absence or Overexpression of the Varicella-Zoster Virus (VZV) ORF29 Latency-Associated Protein Impairs Late Gene Expression and Reduces VZV Latency in a Rodent Model , 2006, Journal of Virology.

[94]  D. Whitelaw OBSERVATIONS ON HUMAN MONOCYTE KINETICS AFTER PULSE LABELING , 1972, Cell and tissue kinetics.

[95]  T. Shenk,et al.  Human cytomegalovirus genome. , 2008, Current topics in microbiology and immunology.

[96]  I. Hudson,et al.  PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALOVIRUS INFECTION IN INFANTS BY BLOOD FILTRATION TO REMOVE LEUCOCYTES , 1989, The Lancet.

[97]  T. Schwartz,et al.  Selective recognition of the membrane‐bound CX3C chemokine, fractalkine, by the human cytomegalovirus‐encoded broad‐spectrum receptor US28 , 1998, FEBS letters.

[98]  A. Schattenberg,et al.  Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors. , 1990, Transplantation.

[99]  L. Hertel,et al.  Susceptibility of Immature and Mature Langerhans Cell-Type Dendritic Cells to Infection and Immunomodulation by Human Cytomegalovirus , 2003, Journal of Virology.

[100]  T. Giese,et al.  Shaping Phenotype, Function, and Survival of Dendritic Cells by Cytomegalovirus-Encoded IL-101 , 2004, The Journal of Immunology.

[101]  K. Fish,et al.  Reactivation of Latent Human Cytomegalovirus in CD14+ Monocytes Is Differentiation Dependent , 2001, Journal of Virology.

[102]  K. Fish,et al.  Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors , 1997, Cell.

[103]  A. Nikkels,et al.  Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency , 1995, Journal of virology.

[104]  N. Fraser,et al.  Establishment and maintenance of HSV latent infection is mediated through correct splicing of the LAT primary transcript. , 2003, Virology.

[105]  J. Maciejewski,et al.  Characterization of an Antisense Transcript Spanning the UL81-82 Locus of Human Cytomegalovirus , 2005, Journal of Virology.

[106]  W. Gibson,et al.  Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed , 1991, Journal of virology.

[107]  B. Bodaghi,et al.  Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types. , 1999, The Journal of general virology.

[108]  S. Pestka,et al.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[109]  D. Richman,et al.  Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. , 1990, The Journal of infectious diseases.

[110]  M. Daemen,et al.  Cytomegalovirus nucleic acid distribution within the human vascular tree. , 1991, The American journal of pathology.

[111]  S. Straus,et al.  Transcript mapping and transregulatory behavior of varicella-zoster virus gene 21, a latency-associated gene. , 1999, Virology.

[112]  R. Spaete,et al.  A review of genetic differences between limited and extensively passaged human cytomegalovirus strains , 2001, Reviews in medical virology.

[113]  R. Myers,et al.  Coding potential of laboratory and clinical strains of human cytomegalovirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[114]  H. Einsele,et al.  Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. , 1999, The Journal of general virology.

[115]  T. The,et al.  Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products , 1989, Transfusion.

[116]  A. Öst,et al.  Cytomegalovirus infection of human blood cells. , 1984, The Journal of infectious diseases.

[117]  M. Reeves,et al.  Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. , 2007, Blood.

[118]  R. Cohrs,et al.  Characterization of Varicella-Zoster Virus Gene 21 and 29 Proteins in Infected Cells , 2002, Journal of Virology.

[119]  J. L. Stern,et al.  Immunomodulatory Properties of a Viral Homolog of Human Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection , 2008, Journal of Virology.

[120]  E. Mocarski,et al.  Human Cytomegalovirus Latency-Associated Protein pORF94 Is Dispensable for Productive and Latent Infection , 2000, Journal of Virology.

[121]  G. Wilkinson,et al.  Genetic content of wild-type human cytomegalovirus. , 2004, The Journal of general virology.

[122]  E. Mocarski,et al.  Quantitative Analysis of Latent Human Cytomegalovirus , 1999, Journal of Virology.

[123]  K. Lockridge,et al.  Primate cytomegaloviruses encode and express an IL-10-like protein. , 2000, Virology.

[124]  Peter A. Barry,et al.  Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[125]  C. V. van Boven,et al.  High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. , 1990, The American journal of pathology.

[126]  B. Slobedman,et al.  Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. , 2008, Virology.

[127]  H. Einsele,et al.  Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. , 2000, The Journal of general virology.

[128]  T. Raju,et al.  Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. , 1985, The Journal of pediatrics.

[129]  E. Wagner,et al.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. , 1987, Science.

[130]  S. Adler Transfusion-associated cytomegalovirus infections. , 1983, Reviews of infectious diseases.

[131]  E. Mocarski,et al.  Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. , 1995, Scandinavian journal of infectious diseases. Supplementum.

[132]  W. J. Martin,et al.  Cytomegalovirus infections associated with leukocyte transfusions. , 1980, Annals of internal medicine.